What is the incidence of death with benzodiazepine (BZD) withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Death with Benzodiazepine Withdrawal

While benzodiazepine withdrawal can be life-threatening in rare cases, death specifically from benzodiazepine withdrawal alone is uncommon when properly managed, though exact incidence rates are not well documented in the literature. 1, 2

Potential Fatal Complications of Benzodiazepine Withdrawal

  • Abrupt discontinuation of benzodiazepines can lead to severe withdrawal symptoms including seizures, delirium tremens, and in rare cases, death 1, 2
  • Benzodiazepine withdrawal carries greater risks than opioid withdrawal and should always be conducted gradually to prevent potentially fatal complications 2
  • More severe acute withdrawal signs and symptoms can include life-threatening reactions such as convulsions, delirium tremens, hallucinations, and seizures 3

Risk Factors for Severe or Fatal Withdrawal

  • Patients at increased risk of severe withdrawal reactions include those taking higher doses, those with longer durations of use, and those who experience abrupt discontinuation 3
  • Concurrent use of benzodiazepines with opioids significantly increases the risk of fatal outcomes due to respiratory depression 1
  • Patients with a history of seizures or other medical comorbidities are at higher risk for complications during withdrawal 2

Documented Outcomes in Studies

  • A retrospective study at a midwestern academic medical center found no deaths among 82 cases of acute benzodiazepine withdrawal over a 7-year period, though seizures occurred in 10% of cases and 3.6% required endotracheal intubation 4
  • A French retrospective study noted one death possibly linked to benzodiazepine withdrawal syndrome among 16 cases examined 5
  • Withdrawal seizures have been reported with severity ranging from a single episode to coma and death, though specific mortality rates were not provided 6

Proper Management to Reduce Mortality Risk

  • To reduce the risk of fatal outcomes, a gradual tapering schedule is recommended, with reductions of 25% of the initial dose every 1-2 weeks 1, 2
  • When patients are taking both benzodiazepines and opioids that require tapering, it is safer to taper opioids first due to the greater risks associated with benzodiazepine withdrawal 1, 2
  • Cognitive behavioral therapy (CBT) increases tapering success rates and may help prevent complications in patients struggling with benzodiazepine discontinuation 1, 2
  • For patients with a history of withdrawal seizures, referral to a specialist rather than management in primary care is recommended 2

Special Considerations

  • Elderly patients may require a more gradual taper with smaller dose reductions to minimize adverse effects and potential complications 2
  • Patients with co-occurring substance use disorders should be referred to a specialist due to increased complexity and risk 2
  • Monitoring for withdrawal symptoms including increased anxiety, depression, seizures, and altered mental status is essential during the tapering process 2

While benzodiazepine withdrawal can potentially be fatal, death is uncommon when proper tapering protocols are followed. The exact incidence of mortality specifically attributable to benzodiazepine withdrawal is not well established in the literature, but appears to be rare when appropriate medical management is provided.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.